Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via RCPCH
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
For authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
For authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via RCPCH
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 101, Issue 9
TOLVAPTAN USE IN SEVERE NEONATAL AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): THE PHARMACEUTICAL CHALLENGE
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Abstracts from the Neonatal and Paediatric Pharmacists Group (NPPG), 21st Annual Conference, 6–8 November 2015, UK
Poster presentations
P52
TOLVAPTAN USE IN SEVERE NEONATAL AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): THE PHARMACEUTICAL CHALLENGE
Online download statistics by month:
Online download statistics by month: August 2016 to March 2024
Abstract
Full
Pdf
Aug 2016
215
0
59
Sep 2016
150
0
182
Oct 2016
51
0
22
Nov 2016
83
0
32
Dec 2016
55
0
75
Jan 2017
30
0
16
Feb 2017
42
0
7
Mar 2017
66
0
8
Apr 2017
26
0
3
May 2017
43
0
9
Jun 2017
53
0
6
Jul 2017
74
0
5
Aug 2017
62
0
6
Sep 2017
80
0
8
Oct 2017
50
0
3
Nov 2017
44
0
2
Dec 2017
86
0
3
Jan 2018
76
0
9
Feb 2018
58
0
2
Mar 2018
60
0
3
Apr 2018
64
0
4
May 2018
90
0
6
Jun 2018
64
0
4
Jul 2018
34
0
3
Aug 2018
44
0
4
Sep 2018
32
0
2
Oct 2018
51
0
7
Nov 2018
62
0
5
Dec 2018
24
0
2
Jan 2019
40
0
1
Feb 2019
48
0
1
Mar 2019
45
0
2
Apr 2019
53
0
2
May 2019
14
0
0
Jun 2019
53
0
8
Jul 2019
25
0
1
Aug 2019
28
0
2
Sep 2019
24
0
1
Oct 2019
46
0
3
Nov 2019
40
0
4
Dec 2019
55
0
4
Jan 2020
69
0
3
Feb 2020
42
0
1
Mar 2020
30
0
1
Apr 2020
33
0
1
May 2020
28
0
0
Jun 2020
28
0
0
Jul 2020
38
0
3
Aug 2020
20
0
0
Sep 2020
82
0
5
Oct 2020
49
0
2
Nov 2020
21
0
0
Dec 2020
41
0
5
Jan 2021
40
0
0
Feb 2021
14
0
1
Mar 2021
50
0
1
Apr 2021
23
0
2
May 2021
27
0
1
Jun 2021
2
0
3
Jul 2021
0
0
1
Aug 2021
2
0
0
Sep 2021
9
0
1
Oct 2021
16
0
1
Nov 2021
48
0
1
Dec 2021
67
0
1
Jan 2022
45
0
2
Feb 2022
31
0
2
Mar 2022
37
0
2
Apr 2022
40
0
0
May 2022
60
0
0
Jun 2022
56
0
2
Jul 2022
44
0
2
Aug 2022
118
0
2
Sep 2022
36
0
2
Oct 2022
52
0
2
Nov 2022
34
0
0
Dec 2022
32
0
1
Jan 2023
15
0
0
Feb 2023
45
0
2
Mar 2023
18
0
2
Apr 2023
8
0
0
May 2023
25
0
0
Jun 2023
42
0
1
Jul 2023
22
0
0
Aug 2023
17
0
0
Sep 2023
37
0
3
Oct 2023
28
0
1
Nov 2023
20
0
0
Dec 2023
42
0
0
Jan 2024
28
0
0
Feb 2024
18
0
2
Mar 2024
29
0
1
Total
4098
0
589
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via RCPCH
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?